Allogeneic peripheral blood stem cell transplantation (APBSCT) for high-risk hematologic malignancies: The efficacy of tacrolimus (TCL) for the prevention of acute graft-versus-host disease (AGVHD).

被引：0
|
作者：
Uberti, JP [1 ]
Adams, PT [1 ]
Silver, SM [1 ]
Jacobson, PM [1 ]
Scalzo, A [1 ]
Hammelef, K [1 ]
Ayash, L [1 ]
Ratanatharathorn, V [1 ]
机构：
[1] UNIV MICHIGAN,MED CTR,DIV HEMATOL ONCOL,ANN ARBOR,MI
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4514 / 4514
页数：1
相关论文
共 50 条
  • [21] Tacrolimus: a new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantation
    Jacobson, P
    Uberti, J
    Davis, W
    Ratanatharathorn, V
    BONE MARROW TRANSPLANTATION, 1998, 22 (03) : 217 - 225
  • [22] Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantation
    X P Ju
    B Xu
    Z P Xiao
    J Y Li
    L Chen
    S Q Lu
    Z X Huang
    Bone Marrow Transplantation, 2005, 35 : 1179 - 1186
  • [23] Prophylaxis of graft versus host disease with tacrolimus in patients receiving allogeneic peripheral blood stem cell transplantation (allopbsct).
    Uberti, JP
    Silver, SM
    Adams, PT
    Scalzo, A
    Ratanatharathorn, V
    BLOOD, 1996, 88 (10) : 3790 - 3790
  • [24] Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantation
    Ju, XP
    Xu, B
    Xiao, ZP
    Li, JY
    Chen, L
    Lu, SQ
    Huang, ZX
    BONE MARROW TRANSPLANTATION, 2005, 35 (12) : 1179 - 1186
  • [25] Addition of Ruxolitinb to Corticosteroids As First-Line Therapy for High-Risk Acute Graft Versus Host Disease in Allogeneic Peripheral Blood Stem Cell Transplantation
    Dou, Liping
    Zhao, Yanli
    Deng, Lei
    Zhou, Fang
    Wang, Nan
    Jin, Xiangshu
    Li, Fei
    Hu, Liangding
    Liu, Daihong
    BLOOD, 2022, 140 : 1381 - 1382
  • [26] Sirolimus combined with tacrolimus as graft-versus-host disease prophylaxis after allogeneic stem cell transplantation
    Mattsson, J.
    Svenberg, P.
    Gustafsson, B.
    Remberger, M.
    Ringden, O.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S234 - S234
  • [27] Outcome of allogeneic stem cell transplantation for patients with high-risk acute leukemia according to donor type and graft-versus-host disease prophylaxis
    Lindner, S.
    Berg, T.
    Riemann, J.
    Ajib, S.
    Jedlickova, Z.
    Gueller, S.
    Lang, F.
    Sackmann, A.
    Goekbuget, N.
    Martin, H.
    Bacigalupo, A.
    Serve, H.
    Bug, G.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S500 - S501
  • [28] Pentostatin and cyclosporine, a new regimen for the prevention of acute graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation
    Schwartz, JE
    Carroll, MP
    BuchBarker, DM
    Griffin, DL
    Schwartz, RN
    Tompkins, CA
    Donnenberg, AD
    Agha, ME
    Evans, C
    Burgunder, MR
    Yeager, AM
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 50 - 50
  • [29] Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Chen, Yi-Bin
    Shah, Nirav N.
    Renteria, Anne S.
    Cutler, Corey
    Jansson, Johan
    Akbari, Mona
    Chen, Chunlin
    Quadri, Syed
    Parfionovas, Andrejus
    Devine, Steven M.
    BLOOD ADVANCES, 2019, 3 (23) : 4136 - 4146
  • [30] Tacrolimus versus cyclosporine A in prophylaxis of acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in patients with acute leukaemia
    Stankevich, Y.
    Zubarovskaya, L.
    Vavilov, V.
    Bondarenko, S.
    Darskaya, E.
    Kulagin, A.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S153 - S154
12345